Intervention Protocol

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome

  1. Alejandro G Gonzalez Garay1,*,
  2. Ludovic Reveiz2,
  3. Liliana Velasco Hidalgo1,
  4. Cecilia Solis Galicia3

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 14 MAR 2012

DOI: 10.1002/14651858.CD009708

How to Cite

Gonzalez Garay AG, Reveiz L, Velasco Hidalgo L, Solis Galicia C. Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD009708. DOI: 10.1002/14651858.CD009708.

Author Information

  1. 1

    Instituto Nacional de Pediatria, Methodology Research Unit/Neonatology, Mexico City, Distrito Federal, Mexico

  2. 2

    Health Systems Based on Primary Health Care (HSS), Pan American Health Organization, Research Promotion and Development Team, Washington DC, USA

  3. 3

    Instituto Nacional de Pediatria (Cochrane Mexico), Scientitic Information and Documentation, Mexico City, Distrito Federal, Mexico

*Alejandro G Gonzalez Garay, Methodology Research Unit/Neonatology, Instituto Nacional de Pediatria, Insurgentes Sur 3700 - C, Col. Insurgentes Cuicuilco, Coyoacan, Mexico City, Distrito Federal, 04530, Mexico. pegasso.100@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 14 MAR 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the efficacy and safety of ambroxol given to pregnant women at risk of preterm birth to prevent neonatal RDS.